Novavax
NVAX
#5445
Rank
A$1.97 B
Marketcap
A$12.10
Share price
3.58%
Change (1 day)
20.68%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): A$0.60 Billion

According to Novavax's latest financial reports the company's current earnings are A$1.02 Billion. In 2024 the company made an earning of -A$0.22 Billion, an increase over its 2023 earnings that were of -A$0.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.60 B-379.3%
2024 -A$0.22 Billion-70.39%
2023 -A$0.74 Billion-16.59%
2022 -A$0.89 Billion-62.58%
2021 -A$2.36 Billion320.54%
2020 -A$0.57 Billion234.22%
2019 -A$0.17 Billion-30.17%
2018 -A$0.25 Billion1.69%
2017 -A$0.24 Billion-36.44%
2016 -A$0.38 Billion70.4%
2015 -A$0.22 Billion89.27%
2014 -A$0.12 Billion59.83%
2013 -A$72.13 Million81.9%
2012 -A$39.66 Million50.33%
2011 -A$26.38 Million
2009 -A$52.06 Million8.8%
2008 -A$47.85 Million18.01%
2007 -A$40.55 Million18.33%
2006 -A$34.27 Million168.31%
2005 -A$12.78 Million-62.51%
2004 -A$34.07 Million52.4%
2003 -A$22.36 Million-28.21%
2002 -A$31.14 Million
2000 -A$17.75 Million177%
1999 -A$6.41 Million-11.54%
1998 -A$7.25 Million10.64%
1997 -A$6.55 Million-9.62%
1996 -A$7.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.76 B 4,260.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.19 B 2,617.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.64 B 3,662.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$13.77 B 2,538.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.36 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion-176.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$28.77 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.32 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.37 B-28.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA